Literature DB >> 3306285

Elastin degradation.

M J Banda, Z Werb, J H McKerrow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3306285     DOI： 10.1016/0076-6879(87)44184-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  8 in total

1.  Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties.

Authors:  D Campanelli; P A Detmers; C F Nathan; J E Gabay
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms.

Authors:  G P Shi; G K Sukhova; A Grubb; A Ducharme; L H Rhode; R T Lee; P M Ridker; P Libby; H A Chapman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

3.  Characterization of the tpr gene product and isolation of a specific protease-deficient mutant of Porphyromonas gingivalis W83.

Authors:  Y Park; B C McBride
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

4.  Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin.

Authors:  S Katsuda; Y Okada; Y Okada; K Imai; I Nakanishi
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

5.  Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.

Authors:  G K Sukhova; G P Shi; D I Simon; H A Chapman; P Libby
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

6.  Membrane-type 1 matrix metalloproteinase regulates macrophage-dependent elastolytic activity and aneurysm formation in vivo.

Authors:  Wanfen Xiong; Rebecca Knispel; Jason MacTaggart; Timothy C Greiner; Stephen J Weiss; B Timothy Baxter
Journal:  J Biol Chem       Date:  2008-11-14       Impact factor: 5.157

7.  Smooth muscle cells from abdominal aortic aneurysms are unique and can independently and synergistically degrade insoluble elastin.

Authors:  Nathan Airhart; Bernard H Brownstein; J Perren Cobb; William Schierding; Batool Arif; Terri L Ennis; Robert W Thompson; John A Curci
Journal:  J Vasc Surg       Date:  2013-09-27       Impact factor: 4.268

8.  Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme.

Authors:  Anna Laurenzana; Alessio Biagioni; Silvia D'Alessio; Francesca Bianchini; Anastasia Chillà; Francesca Margheri; Cristina Luciani; Benedetta Mazzanti; Nicola Pimpinelli; Eugenio Torre; Silvio Danese; Lido Calorini; Mario Del Rosso; Gabriella Fibbi
Journal:  Oncotarget       Date:  2014-06-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.